Use of the Synthetic Hormone CDB-2914 in Treating Symptoms of Menopause

NCT00009659 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

NIH

Sponsor class

Conditions

Postmenopause

Interventions

DRUG: CDB 2914

Sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)